Doxorubicin
.jpg)
In combination with other antineoplastic drugs, doxorubicin is intended for the treatment of acute lymphocytic leukaemia, except acute lymphatic leukaemia of low risk in children, acute myeloid leukaemia,(Hodgkin- and non-Hodgkin lymphomas), osteosarcoma, Ewing sarcoma, adult soft tissue sarcoma, metastatic breast carcinoma, gastric carcinoma, small-cell lung cancer, neuroblastoma,Wilms tumour and bladder carcinoma.
Doxorubicin may be used intravesically as single agent for treatment and prophylaxis of superficial bladder carcinoma.
